Free Trial
→ Now I look stupid. Real stupid... (From Porter & Company) (Ad) Buy NBIX Stock  Free NBIX Stock Alerts

Neurocrine Biosciences (NBIX) SEC Filings & 10K Form

Neurocrine Biosciences logo
$106.73 +0.97 (+0.92%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$107.36 +0.63 (+0.59%)
As of 04/25/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Neurocrine Biosciences SEC Filings

Export to Excel
DateFilerForm TypeView
04/09/2025
3:04 PM		Neurocrine Biosciences (Filer)
Form DEF 14A
04/09/2025
3:06 PM		Neurocrine Biosciences (Filer)
Form DEFA14A
04/04/2025
7:02 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
1:09 PM		Neurocrine Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
6:13 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:49 PM		Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:57 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:35 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:42 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:13 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:20 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:26 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:00 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:03 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:08 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:33 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM		Neurocrine Biosciences (Subject)
SHERWIN STEPHEN A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
5:41 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:44 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:46 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:48 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:49 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:52 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:56 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
From Social Security to Social Prosperity? (Ad)

In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.

Find out how Trump’s plan could rescue your retirement
02/12/2025
6:00 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:51 PM		Neurocrine Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2025
3:04 PM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
5:50 AM		Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
02/04/2025
5:05 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:42 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:45 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:47 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:49 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:54 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:58 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:31 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:35 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:19 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:32 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:32 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:33 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:34 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:27 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
6:03 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:27 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:19 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:17 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
7:06 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
3:37 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:47 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:29 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
5:52 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
12:41 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:42 PM		Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:52 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
7:31 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:02 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:04 AM		Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
8:54 AM		Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/17/2024
3:21 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:23 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
6:00 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:00 PM		Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:06 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:12 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:21 PM		LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:16 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:18 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
08/05/2024
4:40 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
9:51 AM		Neurocrine Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
6:03 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:04 AM		Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
3:54 PM		LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:00 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:45 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:41 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NBIX) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
The Last Time This Happened, Americans Lost Billions
Wall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...
Banyan Hill Publishing | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Is he more powerful than Trump?
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored